Newsbenzinga
Grail Analyst Sees Massive Market Potential with Valuation Headwinds
· Published
Article summary
RBC initiated coverage of Grail with a Sector Perform rating and $84 target, citing Galleri’s potential and upcoming FDA panel.
An excerpt from the original article.
Comments —
Loading comments…